Zyn is an oral nicotine pouch, a small pouch of nicotine, flavoring, and filler that a user places between the gum and the lip rather than smoking or chewing tobacco leaf. Employees and employers both ask a version of the same question: will using Zyn or a similar pouch cause a problem on a workplace drug test. For a standard drug of abuse panel, the answer is no, nicotine and its metabolites are not one of the analyte classes those panels are built to detect. For a separate, dedicated cotinine test, the answer is yes, and that test does not care whether the nicotine came from a pouch, a cigarette, a vape, or a nicotine patch. This article explains how Zyn and other nicotine pouches are regulated, what a standard panel actually screens for, how cotinine testing works and what it measures, and how state law treats an employer's ability to make decisions based on lawful nicotine use.
What Zyn and other nicotine pouches are
Nicotine pouches are sold as tobacco products under federal law even when they do not contain tobacco leaf, because they deliver nicotine, which the Food and Drug Administration regulates under its tobacco product authority. Manufacturers must take a new nicotine pouch through the FDA's premarket review process before it can be legally marketed, and the agency has been authorizing pouch products under that pathway. The FDA's newsroom page on nicotine pouch authorizations describes this premarket tobacco product review and is clear that authorization to market is not the same thing as a safety approval; it means the agency found the product's likely effect on the population acceptable enough to allow marketing, generally aimed at adults 21 and older who already use tobacco or nicotine products, not at people who do not currently use nicotine. A pouch product should never be described as approved by FDA, and employers and writers covering the category should stick to the term the agency itself uses, authorized for marketing.
Does a standard drug test panel detect Zyn or nicotine
Workplace drug test cups, dip cards, and oral fluid devices use immunoassay chemistry tuned to specific drug of abuse classes: amphetamines, cocaine metabolite, opiates, THC metabolite, PCP, benzodiazepines, barbiturates, methadone, and a handful of others depending on whether the program runs a 5, 10, 12, or larger panel. Nicotine and its main metabolite are not one of those target classes on any standard panel configuration. A person using Zyn, or any other nicotine product, is not expected to trigger a non negative screen on a standard 5, 10, or 12 panel drug test because the panel was never built to look for nicotine in the first place. That is a different question from whether a separate cotinine test would detect it, which it generally will.
What a cotinine test actually measures
Cotinine is the primary metabolite the body produces as it breaks down nicotine, and it is the molecule most nicotine tests are built around rather than nicotine itself. Nicotine clears the body quickly, while cotinine lingers much longer, which is why it is the more reliable marker of recent use. The prescribing information for a nicotine nasal spray product, filed with the National Library of Medicine's DailyMed label repository, describes this directly: cotinine has a half-life of 15 to 20 hours and reaches concentrations roughly 10 times higher than nicotine itself, while nicotine's own elimination half-life from that product runs only 1 to 2 hours. That same NICOTROL NS (nicotine nasal spray) prescribing label on DailyMed also reports that cotinine accounts for about 15 percent of the urinary metabolites and a related compound, trans-3-hydroxycotinine, accounts for about 45 percent. Because cotinine stays measurable for roughly a day or more after nicotine itself has largely cleared, it is the practical biomarker that a dedicated nicotine or cotinine test, run on urine, oral fluid, or blood, is designed to pick up.
Pouches and patches read the same as smoking on a cotinine test
A cotinine test identifies that nicotine was metabolized in the body. It does not identify the source. A person using Zyn or another nicotine pouch, a person smoking cigarettes or cigars, a person vaping, and a person using an over the counter nicotine patch or gum to quit smoking can all produce a positive cotinine result, because all of those products deliver nicotine that the body converts to cotinine through the same metabolic pathway. Secondhand or passive exposure to tobacco smoke can also raise cotinine levels, usually to a much lower concentration than active use, which is why programs that care about this distinction set a specific cutoff concentration rather than reporting any detectable amount as a positive. An employer or insurer reading a cotinine result should understand it as evidence of recent nicotine exposure in general, not evidence of smoking specifically, and definitely not evidence of any drug of abuse.
Screening results still need confirmation
Any immunoassay screen, whether it is a drug of abuse panel or a cotinine test, is a presumptive result. It shows that a chemical reaction crossed a cutoff, not a specific, laboratory grade identification. A result that will be used to make an employment, insurance, or program compliance decision should go to a certified laboratory for confirmation by gas chromatography mass spectrometry (GC/MS) or liquid chromatography tandem mass spectrometry (LC/MS/MS) before anyone treats it as final. Federal drug and alcohol testing programs regulated by the Department of Transportation require a qualified medical review officer (MRO) to review every laboratory confirmed non negative result and to consider any medical or prescription explanation before it reaches the employer; that process is set out in 49 CFR Part 40, the DOT drug and alcohol testing procedures. Cotinine and nicotine testing is not one of the analytes that DOT regulated programs screen for, so a formal MRO review under that specific rule generally does not apply to a voluntary nicotine or cotinine program. Even so, an employer running its own cotinine policy should still build in laboratory confirmation and a documented review step before treating a screening result as grounds for any action, and SAMHSA's workplace drug and alcohol program resources are a reasonable starting point for programs modeling that structure voluntarily.
Why an employer or insurer would test for cotinine at all
A drug of abuse panel exists to keep illegal drugs and misused controlled substances out of a safety sensitive workforce. A cotinine test serves a different purpose. Health systems and a limited number of other employers have adopted nicotine free hiring policies, generally tied to wellness mission or health insurance cost management, and ask applicants to be nicotine free for a defined period before a start date. Life and health insurers also use cotinine testing to confirm whether an applicant qualifies for a non smoker or non tobacco user premium rate. In both cases the test is being used to evaluate lawful personal conduct and product use, not to screen for an illegal substance, and that distinction is exactly what makes the legal landscape around it different from a standard drug panel.
Nicotine products and how they register on a cotinine test
| Product | Contains tobacco leaf | Standard 5/10/12 drug panel target | Dedicated cotinine test result |
|---|---|---|---|
| Zyn and other nicotine pouches | No | No, not a panel analyte | Positive for recent nicotine exposure |
| Cigarettes and cigars | Yes | No, not a panel analyte | Positive for recent nicotine exposure |
| Vapes and e-cigarettes with nicotine | No | No, not a panel analyte | Positive for recent nicotine exposure |
| Nicotine gum, lozenge, or patch (over the counter) | No | No, not a panel analyte | Positive for recent nicotine exposure |
| Nicotine nasal spray or inhaler (prescription) | No | No, not a panel analyte | Positive for recent nicotine exposure |
| Secondhand smoke exposure | Not applicable | No, not a panel analyte | May register at a low concentration, usually below an active use cutoff |
State law and nicotine based hiring decisions
No federal law requires employers to test for nicotine, and outside of a few narrow contexts, no federal law requires an employer to avoid it either. The real limits come from state law, and state law varies widely on whether and how an employer may use lawful, off duty nicotine or tobacco use in a hiring or employment decision. Several states have enacted lawful products or lawful activities statutes that generally protect an employee's or applicant's off premises, off duty use of a legal product, including tobacco and nicotine products, from being used as grounds for an adverse employment action, while still allowing exceptions. North Carolina's version of this type of law is a useful verified example. North Carolina General Statute 95-28.2 makes it generally unlawful for an employer to discriminate against an employee or prospective employee because of lawful use of lawful products off the employer's premises during nonworking hours, but it carves out an exception where the restriction is a bona fide occupational requirement reasonably related to the job or the organization's fundamental objectives, and it separately allows an employer to offer differential insurance rates based on product use as long as the employer gives notice and contributes equally for employees who do not use the product. Other states handle this differently, and some have no such statute at all, so an employer building a nicotine free hiring policy or a cotinine based insurance program should verify the current rule in every state where it operates and loop in employment counsel before finalizing a policy, rather than assuming one state's rule applies everywhere.
Building a defensible nicotine or cotinine testing program
An employer that decides to run a cotinine program, separate from any standard drug of abuse panel, should document the policy in writing, apply it consistently to similarly situated employees and applicants, set a specific cutoff concentration rather than treating any detectable trace as a violation, and route any confirmed result that will affect someone's job or coverage through laboratory confirmation first. Programs built around a nicotine free hiring standard should also think through the ADA and other disability related considerations that can come up around nicotine replacement therapy used for cessation, and generally should treat the policy as a personnel and insurance question that benefits from legal review rather than a straightforward drug safety question. Clinics and employers sourcing their own collection supplies for a cotinine or broader screening program can review options in the dip card collection on americanscreeningcorp.com, and organizations ordering in volume can use the wholesale portal at wholesale.americanscreeningcorp.com to set up an account.
Frequently asked questions
Do Zyn nicotine pouches show up on a standard 5, 10, or 12 panel drug test?
No. Nicotine and its metabolites are not one of the drug classes a standard employment drug test panel is built to detect, so using Zyn or another nicotine pouch would not be expected to trigger a non negative screen on that type of panel.
What does a cotinine test actually detect?
A cotinine test detects cotinine, the primary metabolite the body produces from nicotine. It is a marker of recent nicotine exposure from any source, not a specific drug of abuse test.
Does a cotinine test tell the difference between Zyn, smoking, or a nicotine patch?
No. A positive cotinine result shows recent nicotine exposure in general. It does not identify whether the source was a pouch, a cigarette, a vape, or an over the counter or prescription nicotine replacement product.
Is Zyn approved by FDA?
No. The FDA has authorized certain nicotine pouch products for marketing through its premarket tobacco product review process. Marketing authorization is not the same as an FDA safety approval, and the agency does not use the term approved for this product category.
Can an employer refuse to hire someone for using Zyn or another nicotine product?
It depends on the state. Some states have lawful products statutes that generally limit an employer's ability to base hiring or employment decisions on an applicant's lawful, off duty use of a legal product such as tobacco or nicotine, subject to exceptions, while other states have no such statute. Employers should verify the current rule where they operate and consult employment counsel before adopting a nicotine free hiring policy.
What should happen if someone disputes a positive cotinine or drug test result?
Any non negative immunoassay screen is a presumptive result and should be confirmed by a certified laboratory using GC/MS or LC/MS/MS before it is used for any employment, insurance, or program decision, with documented review of the result before it is finalized.
Related reading: nicotine and cotinine testing for employment and whether smoking cessation medications show up on a drug test.
This article is general information for employers and consumers and is not legal or medical advice. Testing policies and disputed results should be reviewed with qualified employment counsel, a medical review officer, or the testing laboratory.
